Dyne Therapeutics, Inc.
DYN
$18.29
-$0.37-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -111.96M | -108.04M | -110.86M | -115.36M | -89.54M |
| Total Depreciation and Amortization | 521.00K | 523.00K | 503.00K | 502.00K | 450.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.91M | 10.87M | 10.01M | 12.57M | 9.84M |
| Change in Net Operating Assets | -11.31M | 5.87M | 5.64M | -3.60M | -5.09M |
| Cash from Operations | -111.83M | -90.78M | -94.70M | -105.89M | -84.34M |
| Capital Expenditure | -484.00K | -19.19M | -60.00K | -981.00K | -1.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.47M | -18.78M | 6.83M | 2.44M | -14.94M |
| Cash from Investing | 982.00K | -37.97M | 6.77M | 1.46M | -16.01M |
| Total Debt Issued | 49.45M | 0.00 | 98.80M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 381.52M | 217.88M | 1.97M | 141.24M | 3.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.00K | -549.00K | -- | -- | -- |
| Cash from Financing | 430.97M | 217.33M | 100.77M | 141.24M | 3.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.12M | 88.58M | 12.85M | 36.81M | -96.71M |